Literature DB >> 375511

Chemotherapy of echinococcosis with mebendazole: clinical observations of 7 patients.

P Kern, M Dietrich, K J Volkmer.   

Abstract

The effect of high dosage therapy with Mebendazole was studied in 5 patients with cystic echinococcosis and 2 patients with alveolar echinococcosis involving several organs. Follow-up studies at regular intervals from 7 to 20 months indicated an improvement of the pathological findings initially observed. This could clearly be demonstrated by the radiographic findings in cases with pulmonary involvement. The desintegration or dissolution of pulmonary cysts was observed within a few months after treatment with Mebendazole had begun. However, consolidation of previously emptied cysts occurred during the follow-up later. Allergic reactions were observed after commencement of drug therapy in two cases. These were probably due to spillage of antigenic material. The following treatment periods were tolerated well. No serious toxic side effects were observed in the other cases described here.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375511

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN: 0303-4208


  16 in total

1.  CT findings and surgical treatment of double intracranial echinococcal cysts.

Authors:  N Altinörs; Z Kars; C Cepoğlu; L Gürses; S Sağbil; M Ariyürek
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

2.  Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.

Authors:  Mar Siles-Lucas; Adriano Casulli; Roberto Cirilli; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

Review 3.  Chemotherapy for larval echinococcosis in animals and humans: report of a workshop.

Authors:  P M Schantz; H Van den Bossche; J Eckert
Journal:  Z Parasitenkd       Date:  1982

4.  4-Amino-3-(3'-methoxycarbonyl-2'-thioureido)benzophenone, a prodrug of mebendazole.

Authors:  M Dawson; T R Watson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Oct-Dec       Impact factor: 2.441

5.  Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.

Authors:  Cesar M Gavidia; Armando E Gonzalez; Eduardo A Barron; Berenice Ninaquispe; Monica Llamosas; Manuela R Verastegui; Colin Robinson; Robert H Gilman
Journal:  PLoS Negl Trop Dis       Date:  2010-02-23

6.  Chemotherapy of larval echinococcosis with mebendazole: microsomal liver function and cholestasis as determinants of plasma drug level.

Authors:  F Witassek; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Chemotherapy of alveolar echinococcosis. Comparison of plasma mebendazole concentrations in animals and man.

Authors:  F Witassek; B Burkhardt; J Eckert; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Identification of biliary metabolites of mebendazole in the rat.

Authors:  R J Allan; T R Watson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

9.  Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease.

Authors:  P A Braithwaite; M S Roberts; R J Allan; T R Watson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Human echinococcosis: follow-up of 23 patients treated with mebendazole.

Authors:  P Kern
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.